| Melanomas resist T-cell therapy through inflammation-induced reversible dedifferentiation J Landsberg, J Kohlmeyer, M Renn, T Bald, M Rogava, M Cron, M Fatho, ... Nature 490 (7420), 412-416, 2012 | 610 | 2012 |
| The response of autologous T cells to a human melanoma is dominated by mutated neoantigens V Lennerz, M Fatho, C Gentilini, RA Frye, A Lifke, D Ferel, C Wölfel, ... Proceedings of the National Academy of Sciences 102 (44), 16013-16018, 2005 | 547 | 2005 |
| Genetic evolution of T-cell resistance in the course of melanoma progression A Sucker, F Zhao, B Real, C Heeke, N Bielefeld, S Maβen, S Horn, I Moll, ... Clinical Cancer Research 20 (24), 6593-6604, 2014 | 182 | 2014 |
| Temozolomide-and fotemustine-induced apoptosis in human malignant melanoma cells: response related to MGMT, MMR, DSBs, and p53 SC Naumann, WP Roos, E Jöst, C Belohlavek, V Lennerz, CW Schmidt, ... British journal of cancer 100 (2), 322-333, 2009 | 118 | 2009 |
| Immunologic response to the survivin-derived multi-epitope vaccine EMD640744 in patients with advanced solid tumors V Lennerz, S Gross, E Gallerani, C Sessa, N Mach, S Boehm, D Hess, ... Cancer immunology, immunotherapy 63, 381-394, 2014 | 106 | 2014 |
| Melanoma lesions independently acquire T-cell resistance during metastatic latency F Zhao, A Sucker, S Horn, C Heeke, N Bielefeld, B Schrörs, A Bicker, ... Cancer research 76 (15), 4347-4358, 2016 | 77 | 2016 |
| Performance of serum-supplemented and serum-free media in IFNγ Elispot Assays for human T cells S Janetzki, L Price, CM Britten, SH van der Burg, J Caterini, JR Currier, ... Cancer immunology, immunotherapy 59, 609-618, 2010 | 67 | 2010 |
| Exome sequencing to predict neoantigens in melanoma AL Pritchard, JG Burel, MA Neller, NK Hayward, JA Lopez, M Fatho, ... Cancer immunology research 3 (9), 992-998, 2015 | 65 | 2015 |
| Allorestricted T lymphocytes with a high avidity T‐cell receptor towards NY‐ESO‐1 have potent anti‐tumor activity H Krönig, K Hofer, H Conrad, P Guilaume, J Müller, M Schiemann, ... International journal of cancer 125 (3), 649-655, 2009 | 48 | 2009 |
| CD8+ cytotoxic T lymphocytes isolated from allogeneic healthy donors recognize HLA class Ia/Ib–associated renal carcinoma antigens with ubiquitous or restricted … A Dörrschuck, A Schmidt, E Schnürer, M Glückmann, C Albrecht, ... Blood 104 (8), 2591-2599, 2004 | 48 | 2004 |
| CD8+ cytotoxic T lymphocytes isolated from allogeneic healthy donors recognize HLA class Ia/Ib–associated renal carcinoma antigens with ubiquitous or restricted … A Dörrschuck, A Schmidt, E Schnürer, M Glückmann, C Albrecht, ... Blood 104 (8), 2591-2599, 2004 | 48 | 2004 |
| HLA class I loss in metachronous metastases prevents continuous T cell recognition of mutated neoantigens in a human melanoma model B Schrörs, S Lübcke, V Lennerz, M Fatho, A Bicker, C Wölfel, P Derigs, ... Oncotarget 8 (17), 28312, 2017 | 41 | 2017 |
| A key role of GARP in the immune suppressive tumor microenvironment SA Hahn, A Neuhoff, J Landsberg, J Schupp, D Eberts, P Leukel, M Bros, ... Oncotarget 7 (28), 42996, 2016 | 36 | 2016 |
| Superior Antitumor In vitro Responses of Allogeneic Matched Sibling Compared with Autologous Patient CD8+ T Cells S Kausche, T Wehler, E Schnürer, V Lennerz, W Brenner, S Melchior, ... Cancer research 66 (23), 11447-11454, 2006 | 32 | 2006 |
| Evolution of melanoma cross-resistance to CD8+ T cells and MAPK inhibition in the course of BRAFi treatment N Pieper, A Zaremba, S Leonardelli, FN Harbers, M Schwamborn, ... Oncoimmunology 7 (8), e1450127, 2018 | 31 | 2018 |
| Rapid T cell–based identification of human tumor tissue antigens by automated two-dimensional protein fractionation P Beckhove, R Warta, B Lemke, D Stoycheva, F Momburg, M Schnölzer, ... The Journal of clinical investigation 120 (6), 2230-2242, 2010 | 31 | 2010 |
| Generation of CD8+ T cells expressing two additional T-cell receptors (TETARs) for personalised melanoma therapy S Höfflin, S Prommersberger, U Uslu, G Schuler, CW Schmidt, V Lennerz, ... Cancer biology & therapy 16 (9), 1323-1331, 2015 | 28 | 2015 |
| How soluble GARP enhances TGFβ activation S Fridrich, SA Hahn, M Linzmaier, M Felten, J Zwarg, V Lennerz, ... PloS one 11 (4), e0153290, 2016 | 24 | 2016 |
| Identification of NM23-H2 as a tumour-associated antigen in chronic myeloid leukaemia S Tschiedel, C Gentilini, T Lange, C Wölfel, T Wölfel, V Lennerz, ... Leukemia 22 (8), 1542-1550, 2008 | 24 | 2008 |
| Short Peptide Vaccine Induces CD4+ T Helper Cells in Patients with Different Solid Cancers S Gross, V Lennerz, E Gallerani, N Mach, S Böhm, D Hess, ... Cancer immunology research 4 (1), 18-25, 2016 | 20 | 2016 |
